Johannes Lutz
Paul Ehrlich Str. 15
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
mRNA-based immunotherapy improves the efficacy of adoptively transferred TCR transgenic T cells in a murine solid tumour model.
Journal: Scientific reports
Published: December 04, 2025
Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma.
Journal: Cancer immunology, immunotherapy : CII
Published: July 02, 2025
Sequence-Optimized mRNA Vaccines Against Infectious Disease.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 30, 2024
Local immunotherapy with the RNA-based immune stimulator CV8102 induces substantial anti-tumor responses and enhances checkpoint inhibitor activity.
Journal: Cancer immunology, immunotherapy : CII
Published: August 31, 2022
To which world regions does the valence-dominance model of social perception apply?
Journal: Nature human behaviour
Published: May 18, 2018
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.
Journal: NPJ vaccines
Published: May 06, 2017
mRNA Cancer Vaccines.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Published: January 20, 2017
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 18, 2016
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
Journal: International journal of cancer
Published: June 30, 2014
Construct validity of the Anxiety Sensitivity Index-3 in clinical samples.
Journal: Assessment
Published: December 14, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026